46.46.Z - Wholesale of pharmaceutical goods
46.75.Z - Wholesale of chemical products
46.76.Z - Wholesale of other intermediate products
47.91.Z - Retail sale via mail order houses or via Internet
47.99.Z - Other retail sale not in stores, stalls or markets
71.20.B - Other technical testing and analysis
72.11.Z - Research and experimental development on biotechnology
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
77.39.Z - Rental and leasing of other machinery, equipment and tangible goods not elsewhere classified
96.09.Z - Other personal service activities not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 24,1 | 4 | -0,6 | -113,9 |
EBITDA | 24,7 | 3,8 | -0,2 | -105 |
Short time liabilities | 1,5 | 8 | 7,3 | -9,3 |
Equity capital | 17,5 | 7,2 | 6,6 | -7,8 |
Operating profit (EBIT) | 24,6 | 3,6 | -0,4 | -112,4 |
Assets | 19 | 15,2 | 13,9 | -8,7 |
Net profit (loss) | 24,1 | 3,3 | -0,6 | -116,8 |
Cash | 10,3 | 8,7 | 8,5 | -2,5 |
Net income from sale | 63,5 | 18,9 | 9 | -52,4 |
Liabilities and provisions for liabilities | 1,5 | 8 | 7,3 | -9,5 |
Working assets | 18,7 | 14,1 | 13 | -7,5 |
Depreciation | 0,1 | 0,2 | 0,3 | 57,2 |
% | % | % | p.p. | |
Profitability of capital | 137,4 | 46,1 | -8,4 | -54,5 |
Equity capital to total assets | 92,1 | 47,1 | 47,6 | 0,5 |
Gross profit margin | 37,9 | 21 | -6,1 | -27,1 |
EBITDA Margin | 39 | 19,9 | -2,1 | -22 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 9 | 155 | 295 | 140 |
Current financial liquidity indicator | 1.2086886167526245 | 1.754881501197815 | 1.7927660942077637 | 0 |
Net dept to EBITDA | -3.50382137298584 | -2.3118579387664795 | 45.21919631958008 | 47,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane